Head-to-head decision matrix

Quantum risk monitor vs Vertigo relief app

Quantum risk monitor best fits the Research Strategist (60/100 fit), while Vertigo relief app best fits the Market Insider (51/100 fit). Choose by the founder advantage you can actually bring to the first validation sprint.

adjacent vertical headlongmanagementspecifically
Legal & Risk

Quantum risk monitor

Enterprises run thousands of systems that depend on quantum-vulnerable RSA and elliptic-curve cryptography, but most have no accurate, continuously updated inventory of where those algorithms are used (in certificates, TLS endpoints, libraries, SSH keys, code, and firmware). Without that visibility they cannot prioritize migration, prove regulatory compliance, or quantify their 'harvest-now-decrypt-later' exposure for long-lived sensitive data.

Verdict
Research / 50/100
Confidence
58%
Difficulty
high
Founder fit
Researcher / 60/100
Proof average
6.3/10
Read full report
Healthcare

Vertigo relief app

BPPV is the most common vestibular disorder, yet sufferers face long waits for ENT/vestibular specialists and struggle to perform repositioning maneuvers like the Epley correctly at home from static diagrams. Without guided head-positioning, episode tracking, and recurrence coaching, patients self-treat incorrectly, relapse (recurrence occurs in roughly half of cases), and miss daily activities.

Verdict
Research / 56/100
Confidence
58%
Difficulty
moderate
Founder fit
Insider / 51/100
Proof average
6.3/10
Read full report

Validation criteria

Same rubric, side by side.

Bars use the existing report visual scale, with each criterion scored out of 10.

Demand signal

Quantum risk monitor 6/10

Demand looks thin because the report has 4 source-backed signal(s), an editorial confidence of 58/100, and a defined buyer in Enterprise cybersecurity / GRC tooling — specifically post-quantum cryptography (PQC) readiness and crypto-agility management for large regulated organizations and government contractors.

Vertigo relief app 6/10

Demand looks thin because the report has 4 source-backed signal(s), an editorial confidence of 58/100, and a defined buyer in Consumer digital health for vestibular disorders, specifically BPPV and dizziness self-management, within the broader telerehabilitation and digital therapeutics space..

Problem severity

Quantum risk monitor 6.3/10

Problem severity is thin when the buyer pain, customer value, and dream-outcome scores are combined.

Vertigo relief app 6.3/10

Problem severity is thin when the buyer pain, customer value, and dream-outcome scores are combined.

Willingness to pay

Quantum risk monitor 5/10

Willingness to pay is weak; the model has a monetization hypothesis, but it must still be proven through paid pilots or explicit pricing objections.

Vertigo relief app 5.5/10

Willingness to pay is weak; the model has a monetization hypothesis, but it must still be proven through paid pilots or explicit pricing objections.

Competitive saturation

Quantum risk monitor 3.1/10

Competitive room is reduced by 3 recorded alternative(s); the wedge must stay narrow and differentiated.

Vertigo relief app 3.9/10

Competitive room is reduced by 3 recorded alternative(s); the wedge must stay narrow and differentiated.

Feasibility

Quantum risk monitor 4/10

Feasibility is weak for a high build if the MVP is limited to the first measurable workflow.

Vertigo relief app 6.2/10

Feasibility is thin for a moderate build if the MVP is limited to the first measurable workflow.

Revenue and GTM

Quantum risk monitor

Revenue: $250K-$2M ARR potential if the wedge proves budget urgency and becomes a recurring workflow.

GTM: Start with manual concierge output, direct outreach, and community proof before paid acquisition.

Execution: Execution is high; the main constraint is staying narrow enough for a first proof loop.

Vertigo relief app

Revenue: $250K-$2M ARR potential if the wedge proves budget urgency and becomes a recurring workflow.

GTM: Start with manual concierge output, direct outreach, and community proof before paid acquisition.

Execution: Execution is moderate; the main constraint is staying narrow enough for a first proof loop.

Which founder should pick which?

Quantum risk monitor best fits the Research Strategist (60/100 fit), while Vertigo relief app best fits the Market Insider (51/100 fit). Choose by the founder advantage you can actually bring to the first validation sprint.

  • Quantum risk monitor: You spot uneven information quality, package evidence, and sell clarity to teams that make repeated decisions.
  • Vertigo relief app: You have access to a niche buyer community and can validate painful workflows faster than a generalist.